Preclinical Research

News Headlines

On your radar

All news articles

News headlines > Preclinical Research

Email this page News by email Send a press-release

F&S identify data build-up key to sector growth

22-Nov-2005 - The need to analyse voluminous data is set to create a wealth of opportunities for bioinformatics in which systems integration capabilities are predicted to boost uptake of bioinformatics and clinical informatics in drug discovery and development.

Pfizer collaboration could net Incyte $800 million

22-Nov-2005 - Pfizer and Incyte have entered a collaborative research and license agreement for the development and commercialisation of CCR2 antagonists - an emerging class of drug that aims to serve an unmet need in the treatment of rheumatoid arthritis and insulin-resistant obese patients.

Millipore offers purifying and protein concentrating devices

17-Nov-2005 - Millipore Corporation today announced two tangential flow filtration (TFF) products that allow researchers to efficiently purify large volumes of protein-containing solutions that accelerate drug screening and improve sample preparation.

Schering-Plough uses OMS Technology in new deal

17-Nov-2005 - Schering-Plough has entered into an agreement with Oncomethylome Sciences (OMS), which allows the pharma giants to use OMS Pharmacogenomic technology to study MGMT methylation status in brain cancer patients.

Aptuit acquires InfoPro Solutions

15-Nov-2005 - Drug development services company, Aptuit, has finalised a deal to acquire InfoPro Solutions, which adds informatics services to Aptuit's portfolio, as well as the Clinicopia Suite, which enables customer access to drug development data and information.

Pain Therapeutics and King Pharma enter opioid alliance

14-Nov-2005 - Pain Therapeutics and King Pharmaceuticals have entered into an alliance to develop and commercialise Remoxy in an alliance worth at least $400 million (€342 million). The deal positions the abuse-resistant opioid painkiller as a major new class of drug.

Sophion deal aims to expand into Japanese market

10-Nov-2005 - Sophion Bioscience and Physio-Tech have signed an agreement in which Physio-Tech will become the exclusive distributor of Qpatch 16 systems in Japan, signifying its introduction into the Asian market.

Varian acquires UK's Polymer Labs

10-Nov-2005 - Varian has announced it is to acquire Polymer Laboratories for $42 million (€35.7 million)in a transaction that adds consumables and instrumentation for Gel Permeation Chromatography (GPC) analysis to its product portfolio.

GSK signs supplier agreement with Xceleron

08-Nov-2005 - Contract research specialists Xceleron have announced a new three-year deal that provides support for GSK's bioanalytical AMS programme for human metabolite profiling and obtaining mass balance data.

Simulations Plus releases ADMET Predictor add-on

01-Nov-2005 - Simulations Plus has announced the release of a new hERG potassium channel blocking affinity model that extends the capabilities of its ADMET Predictor software in the area of cardiac drug toxicity.

Biolex and Kringle collaborate on protein targeting cancer

27-Oct-2005 - Biolex Therapeutics and Kringle Pharma have announced a collaboration for the production of a novel protein targeting cancer. The protein is thought to be inefficient to produce with traditional expression systems.

Medisyn agrees natural compound collaboration

25-Oct-2005 - Medisyn Technologies has entered into agreement with Humanetics that aims to drive the discovery of natural compounds that can offer safe, natural therapeutic options in the areas of obesity, immune system and cognitive function.

Research Dynamics enters CRO service agreement

20-Oct-2005 - Research Dynamics have struck a deal with VirtualScopics in which they have signed a non-exclusive partnership agreement to co-market their clinical research services and technologies.

Roche and Epitomics enter rabbit MAbs agreement

18-Oct-2005 - Roche has formed a research collaboration with Epitomics, giving Roche a license to Epitomics' monoclonal antibody technology (RabMab technology) for the discovery and development of monoclonal antibodies to treat cancer and other diseases.

Seaweed compounds show HIV efficacy

13-Oct-2005 - Researchers have discovered a species of seaweed that could yield new compounds with pharmaceutical potential, some of which showed the potential to kill cancer cells, bacteria and even the HIV virus.

Knowledge-based economy ensures life sciences funding

11-Oct-2005 - Life sciences is to be given priority under a European Commission (EU) framework, which focuses on creating a knowledge-based economy to ensure increased funding for this industry.